In the Life Sciences industry there exists a challenge between innovation and cost effectiveness. This is driven by global competition, regulation, cost and price pressures, transparency and collaboration. Companies in this sector, large and small are seeking to transform, to meet these demands by finding improvements in all functions and processes, core and non-core.
Improved use of technology and enabling transformation, is not only aimed at product development, manufacturing and distribution, but also at improving engagement with regulators, payers, providers and ultimately the end user or customer. The key challenges for IT are expanding from supporting the current business processes, to a much wider list, starting with cost efficiencies and optimisation in the present IT operations, to supporting transformational change.
New digital capabilities such as “big data” analytics, higher productivity, mobile enabling the workforce or driving supply chain efficiencies, all require careful assessment of the current “business as usual” IT operations before change can occur. The pressure to move, requires informed decision support.
“We chose ImprovIT due to a combination of cost and capability. They proved to be excellent Value for Money”
Life Sciences, Global IT Director
ImprovIT works with small and large companies in this sector, to bring specialist and independent IT benchmarking, measurement and modelling tools to the table, to help drive IT performance, efficiency and improve the value delivered from technology spend.
“I like ImprovIT’s methodology, they stand out from the rest”
Life Sciences, Director Infrastructure Programmes
Often with heterogeneous service models – with a mix of in-house, outsourced and cloud delivered services – there are observations and recommendations which emanate from the analysis. These highlight and inform a range of tactical and strategic IT issues. While validating and evidencing value, the outcomes also help focus attention on areas where intervention is required, where change can be valuable given the market evidence. These areas may be one or more, such as:
This forward-looking view assists IT executives to focus attention on IT transformation, to help the business meet its challenges and bring “science and technology” closer.